If you could vote on Brexit now which option would you choose?

Moderna expects COVID-19 vaccine trial data for children aged 2-5 in March

Moderna Inc said on Wednesday it expects to report data from its COVID-19 vaccine trial in children aged between 2 to 5 years in March. 'If the data is supportive and subject to regulatory consultation, Moderna may proceed with regulatory filings for children 2-5 years of age thereafter,' the company said. Moderna's vaccine, based on the messenger RNA platform, already has authorizations in Europe, UK, Australia, and Canada for adolescents aged 12-17 years, and has submitted applications for children in 6 to 11 years.

Reuters - January 13, 2022

View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-expects-covid-19-vaccine-trial-data-children-aged-2-5-march-2022-01-12/